
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. The company is progressing one of its lead assets, Galidesivir, on two fronts. It announced yesterday that screening and preparation requirements had been completed for 22 non-human primates (NHPs) for a planned 20-animal Galidesivir dose optimisation study at USAMRIID, with dosing expected in the December 2026 quarter. Meanwhile,…


